RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
47 hedge funds and large institutions have $34.2M invested in Regulus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 10 closing their positions.
Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
13
Closed
10
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
–
Top Buyers
1 |
AC
1
Ascend Capital
Orinda,
California
|
$705K |
2 |
![]()
2
Fidelity Investments
Boston,
Massachusetts
|
$10.3M |
3 |
3
Invesco
Atlanta,
Georgia
|
$13K |
4 |
4
Goldman Sachs
New York
|
$11K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$10K |
Top Sellers
1 |
BI
1
BVF Inc
San Francisco,
California
|
$9.02M |
2 |
2
DZ Bank
Frankfurt Am Main,
Germany
|
$0 |
3 |
3
BlackRock
New York
|
$386K |
4 |
ARTA
4
A.R.T. Advisors
New York
|
$24K |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$1.75M |